RhumbLine Advisers’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Buy |
|
|||||
|
2025
Q1 | $86K | Buy |
|
|||||
|
2024
Q4 | $126K | Buy |
|
|||||
|
2024
Q3 | $131K | Buy |
|
|||||
|
2024
Q2 | $123K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $166K | Buy |
|
|||||
|
2020
Q4 | $187K | Buy |
|
|||||
|
2020
Q3 | $105K | Buy |
|
|||||
|
2020
Q2 | $127K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $136K | Sell |
|
|||||
|
2018
Q4 | $134K | Buy |
|
|||||
|
2018
Q3 | $128K | Buy |
|
|||||
|
2018
Q2 | $136K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $178K | Sell |
|
|||||
|
2013
Q4 | $161K | Sell |
|
|||||
|
2013
Q3 | $220K | Sell |
|
|||||
|
2013
Q2 | $178K | Buy |
|